Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Jennifer B. Green et al.|The Lancet|2018Cited by 1.8k
Guidance for the treatment of deep vein thrombosis and pulmonary embolismMichael B. Streiff, Jack Ansell, Giancarlo Agnelli et al.|Journal of Thrombosis and Thrombolysis|2016Cited by 343
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and AnemiaJeffrey L. Carson, John H. Alexander, Maria M. Brooks et al.|New England Journal of Medicine|2023Cited by 244
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevationRenato D. Lópes, Christopher B. Granger, Karen S. Pieper et al.|Heart|2008Cited by 187
Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure–Related OutcomesMarat Fudim, Robert J. Mentz, Jennifer A. White et al.|Circulation|2019Cited by 95